Skip to main content
CONTEC MEDICAL SYSTEMS CO., LTD. logo

CONTEC MEDICAL SYSTEMS CO., LTD. — Investor Relations & Filings

Ticker · 300869 ISIN · CNE1000047F0 LEI · 6556007SL3V6YKCWVA55 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 789 across all filing types
Latest filing 2023-04-26 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 300869

About CONTEC MEDICAL SYSTEMS CO., LTD.

https://www.contecmed.com.cn

CONTEC Medical Systems Co., Ltd. focuses on the research, development, manufacturing, and distribution of medical electronic instruments. The product portfolio encompasses a wide range of diagnostic and monitoring solutions, including pulse oximeters, blood pressure monitors, electrocardiographs, ultrasound equipment, and multi-parameter patient monitors. Additionally, the company provides specialized devices such as fetal monitors, sleep apnea screening systems, and biochemical analyzers. By leveraging integrated research and large-scale production facilities, the organization delivers medical technology designed for clinical, hospital, and home healthcare environments. The company emphasizes technical innovation and adheres to international quality standards to ensure the precision and reliability of its medical hardware and software solutions.

Recent filings

Filing Released Lang Actions
2022年年度审计报告
Audit Report / Information Classification · 95% confidence The document is titled as "财务报表及审计报告 2022 年 12 月 31 日止年度" which translates to "Financial Statements and Audit Report for the year ended December 31, 2022." It contains detailed financial statements including consolidated and parent company balance sheets, income statements, cash flow statements, equity changes, and extensive notes. It also includes a comprehensive audit report with auditor opinions, key audit matters, management responsibilities, and auditor responsibilities. The document length is about 15,000 characters, indicating it is a full report rather than a brief announcement. The presence of a full audit report and detailed financial statements indicates this is an Audit Report / Information filing rather than a full Annual Report (10-K) or just an announcement. Therefore, the document is best classified as an Audit Report / Information (AR). FY 2022
2023-04-26 Chinese
关于变更可转债募集资金用途的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from 康泰医学系统（秦皇岛）股份有限公司 regarding the change in the use of funds raised from a convertible bond issuance. It details the original fundraising, the amount raised, the projects involved, and the board and supervisory approvals for the change in fund allocation. The document includes detailed project descriptions, investment amounts, and economic benefit analyses. It is a formal disclosure about the change in capital use, not a financial report or earnings release. It does not contain financial statements or quarterly results but focuses on capital/financing update related to the use of raised funds. Therefore, the document fits best under the category of Capital/Financing Update (CAP).
2023-04-26 Chinese
监事会决议公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 15th meeting of the third Supervisory Board of Kangtai Medical System (Qinhuangdao) Co., Ltd. It includes approvals of various reports such as the 2022 Annual Report, 2022 Audit Report, 2023 Q1 Report, internal control report, profit distribution plan, and other corporate governance matters. However, the document itself does not contain the full reports or financial statements but refers to these reports being available on the CNINFO website. The document is a formal meeting resolution announcement summarizing the supervisory board's review and approval of these reports and proposals, which will be submitted to the shareholders' meeting for further approval. The document length is under 5,000 characters and primarily serves as a meeting resolution announcement rather than the reports themselves. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and meeting resolutions disclosure, not as the actual annual report or audit report.
2023-04-26 Chinese
独立董事2022年度述职报告（彭勋）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director 2022 Annual Work Report" for 康泰医学系统（秦皇岛）股份有限公司. It details the independent director's attendance at board and shareholder meetings, opinions on various board resolutions, committee work, investigations, and efforts to protect investor rights during the 2022 fiscal year. The content is a detailed report on the independent director's activities and responsibilities over the year, rather than an announcement or a brief summary. It does not contain financial statements or audit results but focuses on governance and management oversight. This fits best under Board/Management Information (MANG), which covers announcements related to board or senior management activities and reports. The document length is 3005 characters, which is not extremely short, and it is a substantive report rather than a simple announcement or certification. Therefore, the classification is MANG with high confidence.
2023-04-26 Chinese
中信建投证券股份有限公司关于康泰医学系统（秦皇岛）股份有限公司拟开展金融衍生品交易业务的核查意见
Regulatory Filings Classification · 95% confidence The document is a detailed opinion and verification report from a securities company (中信建投证券股份有限公司) acting as a sponsor for 康泰医学系统（秦皇岛）股份有限公司 regarding the company's planned financial derivatives trading business. It includes investment purpose, scope, risk analysis, risk control measures, and opinions from the board, supervisory committee, independent directors, and the sponsor. The document is regulatory in nature, related to compliance and approval of a specific financial activity, but it is not a financial report, earnings release, or capital update. It is not a short announcement but a substantive verification opinion. This fits best under Regulatory Filings (RNS) as it is a compliance and regulatory disclosure document that does not fit other categories like Capital/Financing Update or Audit Report. The document length is 3357 characters, which is relatively short but contains detailed regulatory content rather than just an announcement of a report publication.
2023-04-26 Chinese
康泰医学2022年度内部控制自我评价报告
Audit Report / Information Classification · 95% confidence The document is titled as an "Internal Control Self-Evaluation Report" for the year ending December 31, 2022, issued by 康泰医学系统（秦皇岛）股份有限公司. It details the company's internal control evaluation, including scope, methodology, and conclusions about the effectiveness of internal controls over financial reporting and other business processes. The document includes detailed descriptions of internal control systems, risk assessments, and compliance with regulatory standards. It is a comprehensive report on internal control effectiveness rather than a brief announcement or certification. It does not fit categories like Annual Report (10-K), Earnings Release (ER), or Regulatory Filings (RNS) since it contains substantive evaluation content. It is not a standalone audit report but an internal control evaluation report. Given the definitions, the closest fitting category is Audit Report / Information (AR), which includes internal or regulatory stress tests and applied accounting principles, and standalone audit-related reports excluding full annual reports. The document is not a financial statement but an internal control evaluation report, which aligns with AR. FY 2022
2023-04-26 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.